Skip to main content

ESSA Pharma Inc.

EPIXDelisted Oct 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001633932

ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding ESSA Pharma Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of EPIX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders31132+2
Shares35.2M5.61K35.1M−99.7K (−0.3%)
Value$185.1M$29.5K$212.7M+$27.7M (+14.9%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held ESSA Pharma Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to EPIX in Q3 2024
InstitutionSharesValue% of portfolio
Group One Trading, L.P.27,795$168.4K0.01%
BlackRock, Inc.5,609$34.0K0.00%
Simplex Trading, LLC5,162$31.0K0.00%
Truvestments Capital LLC846$5.13K0.00%
Barclays PLC355$2.15K0.00%

Sold out (3)

Institutions that held ESSA Pharma Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of EPIX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Janus Henderson Group PLC1,006,202$5.19M
Two Sigma Investments, LP10,313$54.2K
Toronto Dominion Bank48$252

Not filed for Q3 2024 yet (1)

Institutions that held ESSA Pharma Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EPIX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.5,609$29.5K